Caption Management, LLC Krystal Biotech, Inc. Transaction History
Caption Management, LLC
- $9.8 Billion
- Q4 2024
A detailed history of Caption Management, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 78,500 shares of KRYS stock, worth $12 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
78,500
Previous 36,000
118.06%
Holding current value
$12 Million
Previous $6.55 Million
87.86%
% of portfolio
0.13%
Previous 0.11%
Shares
4 transactions
Others Institutions Holding KRYS
# of Institutions
302Shares Held
24.5MCall Options Held
444KPut Options Held
325K-
Black Rock Inc. New York, NY3.95MShares$605 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$441 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.63MShares$403 Million6.0% of portfolio
-
State Street Corp Boston, MA1.28MShares$196 Million0.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$151 Million9.67% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $3.93B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...